Trusted Resources: People & Places
Online groups, photo galleries and blogs
Walla Al-Hertani, MD, MS, FRCPC, FCCMG, FACMG
Healthcare Professional Director
Lysosomal Storage Disease Program (BoLD)
Boston Children's Hospital
300 Longwood Avenue, Fegan, 4th Floor
Boston, Massachusetts, United States
Dr. Walla Al-Hertani is a Medical Biochemical Geneticist and a Clinical Geneticist practicing at Boston Children’s Hospital and an Assistant Professor of Pediatrics at Harvard Medical School. She received her Doctor of Medicine degree from Dalhousie University in Halifax, Nova Scotia, followed by the completion of her Clinical Genetics residency in Ottawa and a Biochemical Genetics fellowship at the Hospital for Sick Children and the University of Toronto. Dr. Al-Hertani is currently the Director of the Lysosomal Diseases Program, Glycogen Storage Diseases Program and the Assistant Director of the Metabolism Program at Boston Children’s Hospital. She is actively involved with a number of clinical trials investigating innovative therapies for rare diseases.
Dr. Al-Hertani also specializes in inborn errors off metabolism, lysosomal storage diseases, Glycogen Storage Diseases, Gaucher disease, Pompe Disease, Niemann Pick Disease Type C, MPSI, MPSII, MPSIII, MPSIVA, MPSVI, GSD1a, GSD1b, GSD3, GSD6, GSD9, Methylmalonic acidemia, Propionic acidemia, X-Linked Adrenoleukodystrophy, Peroxisomal disorders, Mitochondrial disorders and Genetic disorders.
Related Content
-
Molecular Analysis of Vietnamese Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis type I (MPS I) is ...
-
CHOC-Harbor UCLA MPS Multidisciplinary CenterCHOC and Harbor-UCLA Pediatrics together...
-
Functional Assessment of the Genetic Findings Indicating Mucopolysaccharidosis Type II in the Prenatal SettingMucopolysaccharidosis type II (MPS II) i...
-
International MPS NetworkCreated in April 1992 by Christine Laver...
-
Mucopolysaccharidosis (MPS)https://slideplayer.com/slide/17257432/...
-
Single Screening of Newborns for 8 Lysosomal Storage Diseases, Including MPS, PossibleResearchers have developed an efficient ...
-
Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type IMucopolysaccharidosis (MPS) type I is a ...